Development of an Antifolate Linker-Drug Technology & Application in IND-Enabling Studies

2:15 pm - Wednesday 10th March 2027

  • Developing a novel linker-drug technology based on a clinically validated mechanism of action
  • Highlighting pharmacology, toxicology, DMPK and differentiation studies
  • Outlining progression of a lead-up in IND-enabling studies

Speakers:

Chief Scientific Officer
Byondis